Vanda Pharmaceuticals Inc. VNDA
NASDAQ · United States · Health Technology
$4.63-0.18 (-3.74%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -1.04 | -0.58 | -78.5% | $50.53M | -18.4% | -3.9%$5.33→$5.12 |
| Q1 2026 | 2026-05-06 | -0.82 | -0.53 | -54.7% | — | — | -13.5%$7.39→$6.39 |
| Q4 2025 | 2026-02-11 | -2.39 | -1.32 | -81.1% | — | — | -17.5%$7.42→$6.12 |
| Q3 2025 | 2025-10-29 | -0.38 | -0.45 | +15.6% | — | — | -22.6%$5.58→$4.32 |
| Q4 2024 | 2025-02-13 | -0.08 | -0.11 | +27.3% | — | — | — |
| Q2 2024 | 2024-07-31 | -0.08 | -0.21 | +61.9% | — | — | — |
| Q1 2024 | 2024-05-09 | -0.07 | 0.05 | -240.0% | — | — | — |
| Q4 2023 | 2024-02-07 | -0.04 | -0.09 | +55.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.